Fundz

Cellply secures €7.15 million in funding to enhance tools for immunotherapy and cell therapy development, led by ENEA Tech and Biomedical.

PRIVATEMay 11, 2026

Amount Raised

€7.15 Million

Round Type

Funding Round

BolognaBiotechnologyArtificial Intelligence

Investors

CDP Venture CapitalBiomedicalENEA Tech

Description

Bologna's Cellply has raised €7.15 million to accelerate the commercial expansion of its innovative VivaCyte® platform. The funding round was led by ENEA Tech e Biomedical, with participation from existing shareholders. This investment aims to advance quality control solutions for cancer therapies and enhance their global adoption. Cellply, founded in 2013, focuses on analytical tools for cell therapies and biotherapeutics.

Quick answer

CellPly raised €7.15 Million in a Funding Round round, dated May 11, 2026. Investors: CDP Venture Capital, Biomedical and ENEA Tech. CellPly is based in Bologna, Emilia Romagna, Italy.

How much did CellPly raise?
CellPly raised €7.15 Million in a Funding Round round on May 11, 2026.
Who invested in CellPly?
CDP Venture Capital, Biomedical and ENEA Tech are named as investors in this round.
What does CellPly do?
Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics.
Where is CellPly based and how big is it?
CellPly is based in Bologna, Emilia Romagna, Italy. Fundz records about 26 employees.
Who are the decision-makers at CellPly?
Fundz holds 1 contact at CellPly, including the Founder & Chief Operating Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at CellPly, and when

A new round usually means CellPly is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CellPly raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CellPly, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CellPly. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CellPly

Location

Bologna, Emilia Romagna, Italy

About

Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CellPly raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMassimo B., Founder & Chief Operating OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CellPly's next move

See what Strategic adds

CellPly raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.